ANTARES PHARMA, INC. – Trademark Portfolio
Entity Type: 03
ANTARES PHARMA, INC. holds 28 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 19 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 4 Nice Classification classes. Currently, 7 trademarks are registered and 5 are pending. Notable registered marks include VIBEX, TLANDO, OTREXUP, XYOSTED, and QUICKSHOT. The owner is based in Ewing, NJ.
Princeton Crossroads Corporate Center
250 Phillips Blvd., Suite 290
Ewing, NJ 08618
Showing of trademarks Trademarks
Trademark Classifications
ANTARES PHARMA, INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does ANTARES PHARMA, INC. have?
ANTARES PHARMA, INC. has 28 U.S. trademarks filed with the USPTO. Of these, 7 registered, 5 pending, 13 abandoned, 3 cancelled.
What trademark classes does ANTARES PHARMA, INC. file in?
ANTARES PHARMA, INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are ANTARES PHARMA, INC.'s most well-known trademarks?
ANTARES PHARMA, INC.'s registered trademark portfolio includes well-known marks such as VIBEX, TLANDO, OTREXUP, XYOSTED, and QUICKSHOT. These are among 7 currently registered trademarks in the portfolio.
What is ANTARES PHARMA, INC.'s trademark registration success rate?
ANTARES PHARMA, INC. has a 30% trademark registration rate, with 7 out of 23 resolved applications resulting in successful registration. Currently, 5 applications are pending review.